Marylebone Health, a leading clinic in human performance and health, has embraced innovative technology from Danish MedTech startup VentriJect to offer quicker and more accessible VO2 max testing. The new Seismofit device provides an efficient method for estimating cardiorespiratory fitness without the need for strenuous exercise, making it suitable for a broader demographic including children, the elderly, and individuals with physical limitations. This advancement not only streamlines the testing process but also enhances the clinic's comprehensive suite of services, catering to both elite athletes and general wellness enthusiasts.
Enhancing Accessibility with Cutting-Edge Technology
The introduction of VentriJect’s Seismofit device marks a significant leap forward in making VO2 max testing more accessible. By utilizing seismocardiography, this device can estimate VO2 max in less than three minutes through a non-invasive method that measures chest movements caused by heartbeats. This approach eliminates the need for intense exercise, which is traditionally required for accurate measurements. As a result, the test becomes feasible for a wider range of clients, from pre/post-operative patients to those with injuries or disabilities.
This innovation aligns perfectly with Marylebone Health’s mission to provide advanced yet accessible health and performance services. The clinic’s expert team of over 40 clinicians, spanning various fields such as NHS practice and high-performance sports, will now be able to offer a more user-friendly alternative to the traditional CPET. This seamless integration into existing fitness methodologies ensures that clients receive top-tier, cutting-edge service while overcoming previous barriers to VO2 max assessment. CEO of VentriJect, Mikkel Kristiansen, expressed enthusiasm about the collaboration, highlighting the growing demand for such technology among premium health providers and fitness centers.
Pioneering Innovation in Health Services
Marylebone Health continues to set the standard for innovation in health and performance services. With the addition of Seismofit, the clinic offers both the gold-standard CPET and the rapid VO2 max estimation, ensuring that clients have multiple options tailored to their needs. Managing Director Liz Moore emphasized the importance of providing easy and effective ways for clients to understand and improve their health. For over a decade, the clinic has been at the forefront of VO2 max testing, and this latest development further solidifies its commitment to excellence.
The integration of Seismofit into Marylebone Health’s offerings reflects a broader trend toward making advanced health assessments more accessible. This device’s ability to deliver clinically validated results quickly and efficiently opens up new possibilities for enhancing overall well-being. Clients can now gain valuable insights into their cardiorespiratory fitness without the constraints of time-consuming and physically demanding tests. As VentriJect’s CEO noted, Seismofit is rapidly becoming indispensable for health providers and fitness clubs, paving the way for a future where precise health metrics are readily available to all.